Literature DB >> 33290055

Kinase Photoaffinity Labeling Reveals Low Selectivity Profile of the IRE1 Targeting Imidazopyrazine-Based KIRA6 Inhibitor.

Dimitris Korovesis1, Nicole Rufo2,3, Rita Derua4,5, Patrizia Agostinis2,3, Steven H L Verhelst1,6.   

Abstract

Inositol-requiring enzyme 1α (IRE1α) is one of three endoplasmic reticulum stress sensors. Upon activation of its kinase domain, IRE1α splices the mRNA substrate XBP1, which activates the unfolded protein response. IRE1α has emerged as a therapeutic target as its hyperactivation is implicated in various diseases. Kinase inhibiting RNase attenuator 6 (KIRA6) is an allosteric IRE1α inhibitor targeting the ATP binding pocket, resulting in effective blockage of the IRE1α-XBP1 pathway in mouse models of diabetes and pain. However, recent studies indicate that KIRA6 is not as selective as initially thought. Here, we developed a photoaffinity-based KIRA6 probe to reveal its selectivity. Surprisingly, the majority of off-targets that we identified were not protein kinases but mostly nucleotide-binding proteins. Furthermore, we found that the promiscuous off-target profile of KIRA6 is not cell-line-dependent. Overall, this study calls for caution when KIRA6 is used in IRE1α-targeted studies and illustrates the power of kinase photoaffinity probes.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33290055     DOI: 10.1021/acschembio.0c00802

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  3 in total

1.  Stress-induced inflammation evoked by immunogenic cell death is blunted by the IRE1α kinase inhibitor KIRA6 through HSP60 targeting.

Authors:  Nicole Rufo; Dimitris Korovesis; Sofie Van Eygen; Rita Derua; Abhishek D Garg; Francesca Finotello; Monica Vara-Perez; Jan Rožanc; Michael Dewaele; Peter A de Witte; Leonidas G Alexopoulos; Sophie Janssens; Lasse Sinkkonen; Thomas Sauter; Steven H L Verhelst; Patrizia Agostinis
Journal:  Cell Death Differ       Date:  2021-08-27       Impact factor: 15.828

2.  Pharmacological Inhibition of Inositol-Requiring Enzyme 1α RNase Activity Protects Pancreatic Beta Cell and Improves Diabetic Condition in Insulin Mutation-Induced Diabetes.

Authors:  Oana Herlea-Pana; Venkateswararao Eeda; Ram Babu Undi; Hui-Ying Lim; Weidong Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-05       Impact factor: 5.555

3.  The IRE1α Inhibitor KIRA6 Blocks Leukotriene Biosynthesis in Human Phagocytes.

Authors:  Xiao Tang; Tarvi Teder; Bengt Samuelsson; Jesper Z Haeggström
Journal:  Front Pharmacol       Date:  2022-03-22       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.